Lisa McDougall
Overview
Explore the profile of Lisa McDougall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chirindel A, Nicolas G, Westerbergh F, McDougall L, Schmid D, Geistlich S, et al.
Eur J Nucl Med Mol Imaging
. 2024 Dec;
PMID: 39633183
No abstract available.
2.
Basaco Bernabeu T, Mansi R, Del Pozzo L, Gaonkar R, McDougall L, Johayem A, et al.
Front Nucl Med
. 2024 Oct;
4:1481343.
PMID: 39464654
Background: Gallium-68 positron emission tomography (Ga-PET) with the two registered somatostatin analogs, [Ga]Ga-DOTA-Tyr-octreotide ([Ga]Ga-DOTA-TOC) and [Ga]Ga-DOTA-Tyr-octreotate ([Ga]Ga-DOTA-TATE), where DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, is routinely used for imaging of somatostatin receptor...
3.
Basaco Bernabeu T, Mansi R, Del Pozzo L, Zanger S, Gaonkar R, McDougall L, et al.
J Nucl Med
. 2024 Jul;
65(9):1427-1434.
PMID: 39025646
The demand for PET tracers that target prostate-specific membrane antigen (PSMA) continues to increase. Meeting this demand with approved Ga- and F-labeled PSMA tracers is challenging outside of major urban...
4.
Rottenburger C, Hentschel M, Furstner M, McDougall L, Kottoros D, Kaul F, et al.
EJNMMI Res
. 2024 Apr;
14(1):37.
PMID: 38581480
Background: A new generation of radiolabeled minigastrin analogs delivers low radiation doses to kidneys and are considered relatively stable due to less enzymatic degradation. Nevertheless, relatively low tumor radiation doses...
5.
Fricke J, Westerbergh F, McDougall L, Favaretto C, Christ E, Nicolas G, et al.
Eur J Nucl Med Mol Imaging
. 2024 Mar;
51(8):2517-2519.
PMID: 38448550
No abstract available.
6.
Eigler C, McDougall L, Bauman A, Bernhardt P, Hentschel M, Blackham K, et al.
J Nucl Med
. 2024 Feb;
65(4):573-579.
PMID: 38423782
Our primary aim was to compare the therapeutic index (tumor-to-bone marrow and tumor-to-kidney absorbed-dose ratios) of the new radiolabeled somatostatin receptor antagonist [Lu]Lu-DOTA-JR11 with the established radiolabeled somatostatin receptor agonist...
7.
Gaonkar R, Wiesmann F, Del Pozzo L, McDougall L, Zanger S, Mikolajczak R, et al.
Pharmaceuticals (Basel)
. 2021 Apr;
14(4).
PMID: 33800582
[Tc]Tc-HYNIC-TOC is the most widely used Tc-labeled somatostatin receptor (SST) agonist for the SPECT imaging of SST-expressing tumors, such as neuroendocrine tumors. Recently, radiolabeled SST antagonists have shown improved diagnostic...
8.
Rottenburger C, Nicolas G, McDougall L, Kaul F, Cachovan M, Vija A, et al.
J Nucl Med
. 2019 Sep;
61(4):520-526.
PMID: 31519804
Treatment of patients with advanced medullary thyroid carcinoma (MTC) is still a challenge. For more than 2 decades, it has been known that the cholecystokinin 2 receptor is a promising...
9.
Nicolas G, Mansi R, McDougall L, Kaufmann J, Bouterfa H, Wild D, et al.
J Nucl Med
. 2017 Apr;
58(9):1435-1441.
PMID: 28450554
Radiolabeled somatostatin receptor (SSTR) antagonists have shown in vivo higher uptake in SSTR-expressing tumors than agonists. In this preclinical study, the SSTR2 antagonist OPS201 (DOTA-JR11; DOTA-[Cpa-c(DCys-Aph(Hor)-DAph(Cbm)-Lys-Thr-Cys)-DTyr-NH]) labeled with Lu, Y,...
10.
Dean M, Hunt J, McDougall L, Rose J
J Reprod Dev
. 2014 Sep;
60(6):438-46.
PMID: 25225159
We have determined uterine glycogen content, metabolizing enzyme expression and activity in the mink, a species that exhibits obligatory embryonic diapause, resulting in delayed implantation. Gross uterine glycogen concentrations were...